Clinical Trials Directory

Trials / Suspended

SuspendedNCT01519297

Preeclampsia: A Marker for Future Cardiovascular Risk in Women

Status
Suspended
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Brigham and Women's Hospital · Academic / Other
Sex
Female
Age
21 Years – 50 Years
Healthy volunteers
Accepted

Summary

This study will compare blood vessel and hormone differences between women who have a history of a pregnancy complicated by preeclampsia or high blood pressure, and women who have a history of uncomplicated pregnancy in the last 10 years. The investigators hypothesize that postpartum women with history of preeclampsia will have altered blood vessel function and abnormal hormone levels compared with postpartum women with history of uncomplicated pregnancy. This study will take place over the course of 2 weeks. Each subject will be assessed on a fixed low-salt diet and a fixed high-salt diet. Subjects will have 2 non-invasive blood vessel imaging tests and fasting blood draws.

Conditions

Interventions

TypeNameDescription
DRUGIrbesartan150mg orally for one dose

Timeline

Start date
2012-05-01
Primary completion
2017-07-01
Completion
2019-07-01
First posted
2012-01-26
Last updated
2019-01-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01519297. Inclusion in this directory is not an endorsement.

Preeclampsia: A Marker for Future Cardiovascular Risk in Women (NCT01519297) · Clinical Trials Directory